Product Recall! Do you have an Allerject pen?
SANOFI CANADA issues voluntary nationwide recall of ALLERJECT® due to potential inaccurate dosage delivery
Do you have an Allerject Pen? Please come in and speak to your Carmi Remedy’s Rx pharmacist.
Sanofi-aventis Canada Inc. (Sanofi Canada) is recalling all Allerject® (epinephrine injection, USP). The voluntary recall involves all Allerject currently on the market and includes both the 0.15 mg/ 0.15 mL and 0.3 mg/0.3 mL strengths for hospitals, retailers and consumers. The products have been found to potentially have inaccurate dosage delivery.
If a patient who is experiencing a serious allergic reaction (i.e., anaphylaxis) did not receive the intended dose, there could be significant health consequences, including death because anaphylaxis is a potentially life-threatening condition.
Canadian customers are asked to immediately return the product to their local pharmacy to obtain an alternate epinephrine auto-injector. In the absence of availability of an alternate epinephrine auto-injector, patients are instructed to retain their Allerject device until an alternate auto-injector is available.
If patients are unable to obtain supplies of alternative epinephrine auto-injectors, and in the event of a life-threatening allergic reaction (anaphylaxis), patients who do not have a replacement product should use their Allerject device, call 911 and immediately seek emergency medical services, in accordance with current product labelling.
Any questions or concerns regarding this voluntary product recall, please contact the Allerject Call Center at 1-855-405-4321.
Any adverse events that may be related to the use of these products should be reported either to:
MedEffect Canada website:
Excerpted from: http://sanoficanada.mediaroom.com/2015-10-28-Sanofi-Canada-Issues-Voluntary-Nationwide-Recall-of-Allerject-Due-to-Potential-Inaccurate-Dosage-Delivery
Carmi Remedy’s Rx – Penticton – Fantastic Healthcare Made Easy!